Market Price Fluctuations and Impairment of Investment Securities
First written in FY2017. 9 of 20 entries say "Materialised", first in FY2017. Latest entry: FY2026.
Taihei Machinery Works,Limited moved to the "Worse" side of this theme in 2017, 2 years before the typical company in this theme (2019).
The whole theme swung hardest in 2019: 70 of 144 companies on the "Worse" side.
40 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「During the consolidated fiscal year, the company recognized an impairment loss of ¥2.873 million on securities, comprising ¥2.873 million on shares classified as other securities.」
An impairment loss of ¥2.873 million was recognized on investment securities in the current period, although no impairment had been recognized in the prior period. - 2026-05-13MaterialisedEarnings forecast revision
「Loss on valuation of investment securities － 3,692」
A loss on valuation of investment securities of ¥3,692 thousand was recorded, whereas none had been recorded in the previous fiscal year, reflecting a loss arising from changes in market prices. - FY2025-H1Decline in Valuation Differences on Other SecuritiesAnnual report
「Valuation difference on available-for-sale securities 34,137 28,060」
The valuation difference on available-for-sale securities decreased from ¥34.137 million at the end of the prior consolidated fiscal year to ¥28.060 million. - FY2024RestatedAnnual report
「3. Securities subject to impairment Current consolidated fiscal year None」
No impairment of investment securities was recognized in the current consolidated fiscal year, and no realization of impairment risk from market price fluctuations has been identified since the prior fiscal year. - FY2024-Q2MitigatedAnnual report
「Other comprehensive income Valuation difference on available-for-sale securities - 659 6,659」
The valuation difference on available-for-sale securities improved from negative ¥659,000 in the prior-year period to ¥6.659 million in the current period, turning positive. - FY2024-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities - 333 4,557」
The valuation difference on available-for-sale securities improved from negative ¥333,000 in the prior-year period to ¥4.557 million in the current period. - FY2023MitigatedAnnual report
「In the prior consolidated fiscal year, the company recognized an impairment loss of ¥5.458 million on securities, comprising ¥5.458 million on shares classified as other securities.」
An impairment loss of ¥5.458 million was recognized in the prior fiscal year, while the loss on the valuation of investment securities was zero in the current consolidated fiscal year. - FY2023-Q3MitigatedAnnual report
「Loss on valuation of investment securities 5,458 -」
The loss on the valuation of investment securities was ¥5.458 million in the prior-year period, compared with zero for the first nine months of the current fiscal year. - FY2022WorsenedAnnual report
「During the consolidated fiscal year, the company recognized an impairment loss of ¥5.458 million on securities, comprising ¥5.458 million on shares classified as other securities.」
An impairment loss of ¥5.458 million was recognized on investment securities, up from ¥4.090 million in the prior consolidated fiscal year. - FY2022-Q2RestatedAnnual report
「Loss on valuation of investment securities 5,458」
A loss on the valuation of investment securities of ¥5.458 million was also recognized for the first six months, unchanged from the first quarter. - FY2022-Q1WorsenedAnnual report
「Loss on valuation of investment securities 5,458」
A loss on the valuation of investment securities of ¥5.458 million was recognized in the first quarter, up from ¥4.090 million in the prior-year period. - FY2021MaterialisedAnnual report
「During the consolidated fiscal year, the company recognized an impairment loss of ¥4.090 million on securities, comprising ¥4.090 million on shares classified as other securities.」
A ¥4.090 million loss on the valuation of investment securities arising from market price fluctuations was recognized for the full year. - FY2021-Q2RestatedAnnual report
「Loss on valuation of investment securities 4,090」
A loss on the valuation of investment securities of ¥4.090 million was recognized as an extraordinary loss for the first six months. - FY2021-Q1MaterialisedAnnual report
「Loss on valuation of investment securities 4,090」
A loss on the valuation of investment securities of ¥4.090 million was recognized in the first quarter, resulting in an actual loss from market price fluctuations. - FY2020MaterialisedAnnual report
「Valuation difference on available-for-sale securities - 24,849」
A negative valuation difference on available-for-sale securities of ¥24.849 million was recognized, reflecting the impact of market price fluctuations. - FY2020-Q2MaterialisedAnnual report
「Valuation difference on available-for-sale securities - 11,954」
The valuation difference on available-for-sale securities was negative ¥11.954 million for the first six months, reflecting the impact of market price fluctuations. - FY2020-Q1MaterialisedAnnual report
「Valuation difference on available-for-sale securities -10,739」
A negative valuation difference on available-for-sale securities of ¥10.739 million was recognized in the first quarter, reflecting market price fluctuations in investment securities. - FY2019RestatedAnnual report
「Loss on sale of investment securities 1,285」
A loss on the sale of investment securities of ¥1.285 million was also recognized for the full year. - FY2019-Q3MaterialisedAnnual report
「Loss on sale of investment securities 1,285」
A loss on the sale of investment securities of ¥1.285 million was recognized during the first nine months. - FY2017MaterialisedAnnual report
「During the consolidated fiscal year, the company recognized an impairment loss of ¥10.475 million on securities, comprising ¥10.475 million on shares classified as other securities.」
The company disclosed market price fluctuation risk for investment securities and recognized an actual impairment loss of ¥10.475 million during the year.